PURE Bioscience, Inc.
PURE
$0.0688
$0.013825.09%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 346.00K | 349.00K | 442.00K | 557.00K | 1.44M |
| Total Receivables | 371.00K | 298.00K | 234.00K | 171.00K | 347.00K |
| Inventory | 72.00K | 56.00K | 74.00K | 74.00K | 104.00K |
| Prepaid Expenses | 47.00K | 27.00K | 44.00K | 62.00K | 100.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 75.00K | 75.00K | 75.00K | 75.00K | 75.00K |
| Total Current Assets | 911.00K | 805.00K | 869.00K | 939.00K | 2.07M |
|
|
|||||
| Total Current Assets | 911.00K | 805.00K | 869.00K | 939.00K | 2.07M |
| Net Property, Plant & Equipment | 13.00K | 13.00K | 51.00K | 147.00K | 184.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 924.00K | 818.00K | 920.00K | 1.09M | 2.25M |
|
|
|||||
| Total Accounts Payable | 718.00K | 601.00K | 506.00K | 409.00K | 652.00K |
| Total Accrued Expenses | 193.00K | 132.00K | 160.00K | 136.00K | 154.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 911.00K | 733.00K | 666.00K | 545.00K | 806.00K |
|
|
|||||
| Total Current Liabilities | 911.00K | 733.00K | 666.00K | 545.00K | 806.00K |
| Long-Term Debt | 3.51M | 2.95M | 2.40M | 1.86M | 1.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.42M | 3.68M | 3.07M | 2.41M | 2.63M |
|
|
|||||
| Common Stock & APIC | 133.79M | 133.73M | 133.69M | 133.66M | 133.60M |
| Retained Earnings | -137.28M | -136.60M | -135.84M | -134.98M | -133.98M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.50M | -2.86M | -2.15M | -1.32M | -383.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.50M | -2.86M | -2.15M | -1.32M | -383.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.50M | -2.86M | -2.15M | -1.32M | -383.00K |
|
|
|||||
